Medical Research Law & Policy Report® Index-Summary

PATENTS

– AIDS/HIV

– – Drug evaluation methods (U.S., rev grant), 685
– – International patent pool, 613

– Bayh-Dole

– – 30th anniversary

– – – Challenges, Special Report, 803
– – – Commemoration

See LEGISLATION, FEDERAL, HConRes 328

– – Tweaks suggested, 751

– Cialis inventorship (Fed. Cir.), 243; (U.S., rev sought), 658
– Cornell, DNA patent claims (D. Del.), 342
– Genetics

– – Australia, breast cancer gene patent challenge (Fed. Ct. Austl.), 367
– – Cornell, DNA patent claims (D. Del.), 342
– – Exception to infringement for gene patents, HHS report, 119
– – Isolated DNA, patent challenge (S.D.N.Y.), 103; patents invalid, Special Report, 228; webinar, Special Report, 353; notice of appeal, 398; recusal sought (Fed. Cir.), 477; brief filed, 515; BNA Insights, 594; comments, 652; briefs (Fed. Cir.), Special Report, 705
– – Licensing of diagnostics and therapeutics, 137
– – Myriad gene patent dispute with PTO (S.D.N.Y.), 40
– – Patentability of genetic sequences, BNA Insights, 428
– – Soya, patent protection for genetic modification, 445

– Mouse strain license agreement (N.D. Cal.), 72; disclosure-dedication rule, 363
– Oncomouse patentability questioned, 364
– Stanford, AIDS therapy, assignment of rights (Fed. Cir.), 13; patents and Bayh-Dole (U.S., briefs sought), 397
– Stem cell research

– – Related patents analysis, 171
– – WARF patent invalid for obviousness (B.P.A.I.), 269

– Tulane peptide analog patent suit (D.D.C.), 28
– Univ. of Ill. cancer drug royalties (7th Cir.), 479
– Univ. of Mo. life sciences startup funding, 114
– Universities filings, survey, 170
– Wis. Alumni Research Found. joint patent licensing (7th Cir.), 44

PAXIL

– Falsified clinical trial records (E.D. La.), 589

PEDIATRIC RESEARCH

See CHILDREN'S HEALTH CARE

PERSONALIZED MEDICINE

– Holistic approach, FDA chief comments, 140
– National system advocacy, 405

PHYSICIANS

– Conflicts of interest

– – Decline in MD-industry ties, 723
– – Ethics code for medical specialty societies, 279
– – Initiative in addressing conflicts, 20
– – Medtronic MD payments, website, 377
– – Orthopedic devices, payments to MDs, 583
– – Positive attitudes toward industry ties, 408
– – Psychiatry, transparency in industry ties sought, 214
– – Streamlining disclosure, FDA action sought, 724
– – Teaching hospitals and MD-industry ties, 407

– Licensing

– – Colo., disclosures for license renewals, 381
– – La. licensing, 381

– Physician-investigator duties, 659
– UK, stem cell physician sanctioned, 630

POSTMARKETING RESEARCH

– Midodrine hydrochloride, proposed retraction of approval, 527

PRIVACY AND CONFIDENTIALITY

– Del. medical records data in research, 457
– HIPAA

– – Business associates, HHS proposed rule imminent, 250
– – Civil rights office, 669
– – Enforcement by HHS civil rights office announced, 250
– – Protecting privacy, BNA Insights, 671
– – UCLA researcher sentencing (C.D. Cal.), 288

– HITECH Act and drug research, 532
– Ohio State Univ., confidentiality of survey records (Ohio Ct. App.), 108
– Opting out of health data collection, 789
– Outlook 2010, 5
– Request for information from HHS, 280
– Restrictive standards, effect on research, 169
– Sweden, destruction of data by researcher, 731
– Tex. newborn blood collection settlement (W.D. Tex.), 25

PRODUCT LIABILITY

– Avandia heart attack suit (E.D. Tex.), 788
– Strict liability, federal jurisdiction (C.D. Cal.), 402

PTO (PATENT AND TRADEMARK OFFICE)

See generally PATENTS